SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Infusion services net revenue	$	1,411,051	$	1,256,455	$	4,115,240	$	3,587,677
Other revenue (1)	23,965		22,091		68,833		64,107
Total Option Care Health revenue	1,435,016		1,278,546		4,184,073		3,651,784
(Expense) Income:
Cost of net revenues - drugs	(1,016,245)		(885,786)		(2,953,923)		(2,510,466)
Salaries, benefits, and other employee expense	(214,594)		(199,723)		(632,481)		(584,835)
Other segment items (2)	(103,379)		(93,287)		(302,986)		(277,393)
Depreciation and amortization expense	(16,291)		(14,659)		(48,278)		(44,294)
Interest expense, net	(14,146)		(12,345)		(41,824)		(38,150)
Equity in earnings of joint ventures	2,176		1,391		5,300		3,921
Other, net	(3,570)		(583)		(8,497)		1,983
Income tax expense	(17,151)		(19,698)		(52,303)		(50,860)
Net Income	$	51,816	$	53,856	$	149,081	$	151,690

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.